Elitepharm Laboratoires
PrivateLast Round
Strategic
Feb 17, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elitepharm Laboratoires operates in Healthcare & Life Sciences and is based in Eckbolsheim. Its latest recorded funding round was a Strategic round in February 2025.
Elitepharm Laboratoires is a contract manufacturing company that specializes in the formulation, development, and production of food supplements and nutraceutical products.
Sector
Healthcare & Life Sciences
Verticals
Smart Manufacturing, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elitepharm Laboratoires Comparables
Compare Elitepharm Laboratoires with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nat'kaps Laboratoire | 94% | |
| Lustrel Laboratoires | 94% | |
| Netlab Pharma | 91% |
For institutional investors. Book with your work email.
Elitepharm Laboratoires Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elitepharm Laboratoires Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Freedom International Group | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 163% MoM.
- Feb 8, 2026
Grew 60% QoQ from 10 to 16 employees.
For institutional investors. Book with your work email.
Elitepharm Laboratoires Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elitepharm Laboratoires's valuation, stock price, and market status.
Is Elitepharm Laboratoires a public or private company?
Elitepharm Laboratoires is a private company.
What is the current stock price of Elitepharm Laboratoires?
Elitepharm Laboratoires is a private company, so its shares have no public market price. Caplight tracks Elitepharm Laboratoires's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elitepharm Laboratoires worth (valuation)?
Valuation information for Elitepharm Laboratoires is not publicly available.
Can I buy Elitepharm Laboratoires stock?
Elitepharm Laboratoires shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elitepharm Laboratoires's last funding round?
Elitepharm Laboratoires's most recent funding round was Strategic on February 17, 2025.
Who are the main investors in Elitepharm Laboratoires?
Key investors in Elitepharm Laboratoires include Freedom International Group.
Will Elitepharm Laboratoires IPO soon?
No public IPO plans have been announced for Elitepharm Laboratoires.
How can I track Elitepharm Laboratoires secondary market activity?
Caplight tracks bids, offers, and trades in Elitepharm Laboratoires's shares on secondary markets.